http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 22 Jul 2026 17:19:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++DarioHealth+Corp.+++++++++For%3A+Jul+22/26802702.html si-local-file:///var/storage/secattach/20260722/26802702.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++DarioHealth+Corp.+++++++++For%3A+Jul+22/26802702.html Wed, 22 Jul 2026 17:19:00 -0400 DRIO O.15219032 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++DarioHealth+Corp.+++++++++For%3A+Jul+22/26802702.html si-local-file:///var/storage/secattach/20260722/26802702.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++DarioHealth+Corp.+++++++++For%3A+Jul+22/26802702.html Wed, 22 Jul 2026 17:19:00 -0400 DRIO O.15219032 http://www.streetinsider.com/SEC+Filings/Form++424B5++++++DarioHealth+Corp.++++++++++++++++++++/26802646.html si-local-file:///var/storage/secattach/20260722/26802646.html http://www.streetinsider.com/SEC+Filings/Form++424B5++++++DarioHealth+Corp.++++++++++++++++++++/26802646.html Wed, 22 Jul 2026 17:14:00 -0400 DRIO O.15219032 http://www.streetinsider.com/SEC+Filings/Form++424B5++++++DarioHealth+Corp.++++++++++++++++++++/26802646.html si-local-file:///var/storage/secattach/20260722/26802646.html http://www.streetinsider.com/SEC+Filings/Form++424B5++++++DarioHealth+Corp.++++++++++++++++++++/26802646.html Wed, 22 Jul 2026 17:14:00 -0400 DRIO O.15219032 http://www.streetinsider.com/Equity+Offerings/DarioHealth+prices+%2423.5+million+direct+stock+offering+at+%246.80+per+share/26798474.html <p>DarioHealth Corp. (NASDAQ: DRIO) announced the pricing of a registered direct offering of 3,454,559 shares of common stock at $6.80 per share, with expected gross proceeds of approximately $23.5 million before placement agent fees and other expenses.</p> <p>A member of the company's board of directors also participated in the offering, purchasing 14,430 shares at $6.93 per share. The offering was priced at-the-market under Nasdaq rules and is expected to close on or about July 23, 2026, subject to customary closing conditions.</p> <p>The offering was led by existing long-term institutional investors, with participation from at least one new institutional investor. A.G.P./Alliance Global Partners http://www.streetinsider.com/Equity+Offerings/DarioHealth+prices+%2423.5+million+direct+stock+offering+at+%246.80+per+share/26798474.html Wed, 22 Jul 2026 08:00:15 -0400 A.50202163 DRIO LS1P O.15219032 O.38677196 http://www.streetinsider.com/Equity+Offerings/DarioHealth+prices+%2423.5+million+direct+stock+offering+at+%246.80+per+share/26798474.html <p>DarioHealth Corp. (NASDAQ: DRIO) announced the pricing of a registered direct offering of 3,454,559 shares of common stock at $6.80 per share, with expected gross proceeds of approximately $23.5 million before placement agent fees and other expenses.</p> <p>A member of the company's board of directors also participated in the offering, purchasing 14,430 shares at $6.93 per share. The offering was priced at-the-market under Nasdaq rules and is expected to close on or about July 23, 2026, subject to customary closing conditions.</p> <p>The offering was led by existing long-term institutional investors, with participation from at least one new institutional investor. A.G.P./Alliance Global Partners http://www.streetinsider.com/Equity+Offerings/DarioHealth+prices+%2423.5+million+direct+stock+offering+at+%246.80+per+share/26798474.html Wed, 22 Jul 2026 08:00:15 -0400 A.50202163 DRIO LS1P O.15219032 O.38677196 http://www.streetinsider.com/Equity+Offerings/DarioHealth+prices+%2423.5+million+direct+stock+offering+at+%246.80+per+share/26798474.html <p>DarioHealth Corp. (NASDAQ: DRIO) announced the pricing of a registered direct offering of 3,454,559 shares of common stock at $6.80 per share, with expected gross proceeds of approximately $23.5 million before placement agent fees and other expenses.</p> <p>A member of the company's board of directors also participated in the offering, purchasing 14,430 shares at $6.93 per share. The offering was priced at-the-market under Nasdaq rules and is expected to close on or about July 23, 2026, subject to customary closing conditions.</p> <p>The offering was led by existing long-term institutional investors, with participation from at least one new institutional investor. A.G.P./Alliance Global Partners http://www.streetinsider.com/Equity+Offerings/DarioHealth+prices+%2423.5+million+direct+stock+offering+at+%246.80+per+share/26798474.html Wed, 22 Jul 2026 08:00:15 -0400 A.50202163 DRIO LS1P O.15219032 O.38677196 http://www.streetinsider.com/Equity+Offerings/DarioHealth+prices+%2423.5+million+direct+stock+offering+at+%246.80+per+share/26798474.html <p>DarioHealth Corp. (NASDAQ: DRIO) announced the pricing of a registered direct offering of 3,454,559 shares of common stock at $6.80 per share, with expected gross proceeds of approximately $23.5 million before placement agent fees and other expenses.</p> <p>A member of the company's board of directors also participated in the offering, purchasing 14,430 shares at $6.93 per share. The offering was priced at-the-market under Nasdaq rules and is expected to close on or about July 23, 2026, subject to customary closing conditions.</p> <p>The offering was led by existing long-term institutional investors, with participation from at least one new institutional investor. A.G.P./Alliance Global Partners http://www.streetinsider.com/Equity+Offerings/DarioHealth+prices+%2423.5+million+direct+stock+offering+at+%246.80+per+share/26798474.html Wed, 22 Jul 2026 08:00:15 -0400 A.50202163 DRIO LS1P O.15219032 O.38677196 http://www.streetinsider.com/Equity+Offerings/DarioHealth+prices+%2423.5+million+direct+stock+offering+at+%246.80+per+share/26798474.html <p>DarioHealth Corp. (NASDAQ: DRIO) announced the pricing of a registered direct offering of 3,454,559 shares of common stock at $6.80 per share, with expected gross proceeds of approximately $23.5 million before placement agent fees and other expenses.</p> <p>A member of the company's board of directors also participated in the offering, purchasing 14,430 shares at $6.93 per share. The offering was priced at-the-market under Nasdaq rules and is expected to close on or about July 23, 2026, subject to customary closing conditions.</p> <p>The offering was led by existing long-term institutional investors, with participation from at least one new institutional investor. A.G.P./Alliance Global Partners http://www.streetinsider.com/Equity+Offerings/DarioHealth+prices+%2423.5+million+direct+stock+offering+at+%246.80+per+share/26798474.html Wed, 22 Jul 2026 08:00:15 -0400 A.50202163 DRIO LS1P O.15219032 O.38677196 http://www.streetinsider.com/Press+Releases/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html <div class="xn-content"> <p class="prntac"><i>The financing was led by continued support of existing long-term institutional investors along with participation from a new global fundamental institutional investor</i></p><p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 22, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth Corp.</span> (NASDAQ: DRIO) (the "Company," "<span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth</span>" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced that it has entered into securities purchase agreements with current long term Dario institutional investors as well as new fundamental investors for the purchase and sale of 3,454,559 shares of common stock (or common stock equivalents http://www.streetinsider.com/Press+Releases/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html Wed, 22 Jul 2026 08:00:00 -0400 A.50202163 DRIO LS1P LS1P LS1P O.15219032 O.38677196 http://www.streetinsider.com/Press+Releases/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html <div class="xn-content"> <p class="prntac"><i>The financing was led by continued support of existing long-term institutional investors along with participation from a new global fundamental institutional investor</i></p><p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 22, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth Corp.</span> (NASDAQ: DRIO) (the "Company," "<span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth</span>" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced that it has entered into securities purchase agreements with current long term Dario institutional investors as well as new fundamental investors for the purchase and sale of 3,454,559 shares of common stock (or common stock equivalents http://www.streetinsider.com/Press+Releases/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html Wed, 22 Jul 2026 08:00:00 -0400 A.50202163 DRIO LS1P LS1P LS1P O.15219032 O.38677196 http://www.streetinsider.com/Press+Releases/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html <div class="xn-content"> <p class="prntac"><i>The financing was led by continued support of existing long-term institutional investors along with participation from a new global fundamental institutional investor</i></p><p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 22, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth Corp.</span> (NASDAQ: DRIO) (the "Company," "<span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth</span>" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced that it has entered into securities purchase agreements with current long term Dario institutional investors as well as new fundamental investors for the purchase and sale of 3,454,559 shares of common stock (or common stock equivalents http://www.streetinsider.com/Press+Releases/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html Wed, 22 Jul 2026 08:00:00 -0400 A.50202163 DRIO LS1P LS1P LS1P O.15219032 O.38677196 http://www.streetinsider.com/Press+Releases/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html <div class="xn-content"> <p class="prntac"><i>The financing was led by continued support of existing long-term institutional investors along with participation from a new global fundamental institutional investor</i></p><p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 22, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth Corp.</span> (NASDAQ: DRIO) (the "Company," "<span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth</span>" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced that it has entered into securities purchase agreements with current long term Dario institutional investors as well as new fundamental investors for the purchase and sale of 3,454,559 shares of common stock (or common stock equivalents http://www.streetinsider.com/Press+Releases/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html Wed, 22 Jul 2026 08:00:00 -0400 A.50202163 DRIO LS1P LS1P LS1P O.15219032 O.38677196 http://www.streetinsider.com/Press+Releases/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html <div class="xn-content"> <p class="prntac"><i>The financing was led by continued support of existing long-term institutional investors along with participation from a new global fundamental institutional investor</i></p><p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 22, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth Corp.</span> (NASDAQ: DRIO) (the "Company," "<span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth</span>" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced that it has entered into securities purchase agreements with current long term Dario institutional investors as well as new fundamental investors for the purchase and sale of 3,454,559 shares of common stock (or common stock equivalents http://www.streetinsider.com/Press+Releases/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html Wed, 22 Jul 2026 08:00:00 -0400 A.50202163 DRIO LS1P LS1P LS1P O.15219032 O.38677196 http://www.streetinsider.com/Press+Releases/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html <div class="xn-content"> <p class="prntac"><i>The financing was led by continued support of existing long-term institutional investors along with participation from a new global fundamental institutional investor</i></p><p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 22, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth Corp.</span> (NASDAQ: DRIO) (the "Company," "<span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth</span>" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced that it has entered into securities purchase agreements with current long term Dario institutional investors as well as new fundamental investors for the purchase and sale of 3,454,559 shares of common stock (or common stock equivalents http://www.streetinsider.com/Press+Releases/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html Wed, 22 Jul 2026 08:00:00 -0400 A.50202163 DRIO LS1P LS1P LS1P O.15219032 O.38677196 http://www.streetinsider.com/Press+Releases/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html <div class="xn-content"> <p class="prntac"><i>The financing was led by continued support of existing long-term institutional investors along with participation from a new global fundamental institutional investor</i></p><p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 22, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth Corp.</span> (NASDAQ: DRIO) (the "Company," "<span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth</span>" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced that it has entered into securities purchase agreements with current long term Dario institutional investors as well as new fundamental investors for the purchase and sale of 3,454,559 shares of common stock (or common stock equivalents http://www.streetinsider.com/Press+Releases/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html Wed, 22 Jul 2026 08:00:00 -0400 A.50202163 DRIO LS1P LS1P LS1P O.15219032 O.38677196 http://www.streetinsider.com/PRNewswire/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html <div class="xn-content"> <p class="prntac"><i>The financing was led by continued support of existing long-term institutional investors along with participation from a new global fundamental institutional investor</i></p><p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 22, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth Corp.</span> (NASDAQ: DRIO) (the "Company," "<span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth</span>" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced that it has entered into securities purchase agreements with current long term Dario institutional investors as well as new fundamental investors for the purchase and sale of 3,454,559 shares of common stock (or common stock equivalents http://www.streetinsider.com/PRNewswire/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html Wed, 22 Jul 2026 08:00:00 -0400 A.50202163 DRIO LS1P LS1P LS1P O.15219032 O.38677196 http://www.streetinsider.com/PRNewswire/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html <div class="xn-content"> <p class="prntac"><i>The financing was led by continued support of existing long-term institutional investors along with participation from a new global fundamental institutional investor</i></p><p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 22, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth Corp.</span> (NASDAQ: DRIO) (the "Company," "<span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth</span>" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced that it has entered into securities purchase agreements with current long term Dario institutional investors as well as new fundamental investors for the purchase and sale of 3,454,559 shares of common stock (or common stock equivalents http://www.streetinsider.com/PRNewswire/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html Wed, 22 Jul 2026 08:00:00 -0400 A.50202163 DRIO LS1P LS1P LS1P O.15219032 O.38677196 http://www.streetinsider.com/PRNewswire/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html <div class="xn-content"> <p class="prntac"><i>The financing was led by continued support of existing long-term institutional investors along with participation from a new global fundamental institutional investor</i></p><p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 22, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth Corp.</span> (NASDAQ: DRIO) (the "Company," "<span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth</span>" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced that it has entered into securities purchase agreements with current long term Dario institutional investors as well as new fundamental investors for the purchase and sale of 3,454,559 shares of common stock (or common stock equivalents http://www.streetinsider.com/PRNewswire/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html Wed, 22 Jul 2026 08:00:00 -0400 A.50202163 DRIO LS1P LS1P LS1P O.15219032 O.38677196 http://www.streetinsider.com/PRNewswire/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html <div class="xn-content"> <p class="prntac"><i>The financing was led by continued support of existing long-term institutional investors along with participation from a new global fundamental institutional investor</i></p><p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 22, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth Corp.</span> (NASDAQ: DRIO) (the "Company," "<span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth</span>" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced that it has entered into securities purchase agreements with current long term Dario institutional investors as well as new fundamental investors for the purchase and sale of 3,454,559 shares of common stock (or common stock equivalents http://www.streetinsider.com/PRNewswire/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html Wed, 22 Jul 2026 08:00:00 -0400 A.50202163 DRIO LS1P LS1P LS1P O.15219032 O.38677196 http://www.streetinsider.com/PRNewswire/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html <div class="xn-content"> <p class="prntac"><i>The financing was led by continued support of existing long-term institutional investors along with participation from a new global fundamental institutional investor</i></p><p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 22, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth Corp.</span> (NASDAQ: DRIO) (the "Company," "<span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth</span>" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced that it has entered into securities purchase agreements with current long term Dario institutional investors as well as new fundamental investors for the purchase and sale of 3,454,559 shares of common stock (or common stock equivalents http://www.streetinsider.com/PRNewswire/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html Wed, 22 Jul 2026 08:00:00 -0400 A.50202163 DRIO LS1P LS1P LS1P O.15219032 O.38677196 http://www.streetinsider.com/PRNewswire/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html <div class="xn-content"> <p class="prntac"><i>The financing was led by continued support of existing long-term institutional investors along with participation from a new global fundamental institutional investor</i></p><p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 22, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth Corp.</span> (NASDAQ: DRIO) (the "Company," "<span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth</span>" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced that it has entered into securities purchase agreements with current long term Dario institutional investors as well as new fundamental investors for the purchase and sale of 3,454,559 shares of common stock (or common stock equivalents http://www.streetinsider.com/PRNewswire/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html Wed, 22 Jul 2026 08:00:00 -0400 A.50202163 DRIO LS1P LS1P LS1P O.15219032 O.38677196 http://www.streetinsider.com/PRNewswire/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html <div class="xn-content"> <p class="prntac"><i>The financing was led by continued support of existing long-term institutional investors along with participation from a new global fundamental institutional investor</i></p><p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 22, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth Corp.</span> (NASDAQ: DRIO) (the "Company," "<span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth</span>" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced that it has entered into securities purchase agreements with current long term Dario institutional investors as well as new fundamental investors for the purchase and sale of 3,454,559 shares of common stock (or common stock equivalents http://www.streetinsider.com/PRNewswire/Dario+Announces+Pricing+of+a+%2423.5+Million+Registered+Direct+Offering+of+Common+Stock+Priced+At-The-Market+Under+Nasdaq+Rules/26798462.html Wed, 22 Jul 2026 08:00:00 -0400 A.50202163 DRIO LS1P LS1P LS1P O.15219032 O.38677196 http://www.streetinsider.com/Press+Releases/Fortune+50+Employer+Awards+Dario+Contract+to+Deliver+AI-Powered+Cardiometabolic+Care+Platform/26776700.html <div class="xn-content"> <p class="prntac"><i>Contract award for over 100,000 eligible employees marks Dario's fifth Fortune 50 client, further reflecting growing demand among large employers for integrated, outcomes-driven chronic condition management</i></p><p class="prntac"><i>Program expected to launch Fall 2026, with revenue contribution beginning by year-end and ramping through 2027</i></p><p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 16, 2026</chron></span> /PRNewswire/ -- <b><span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth Corp.</span> </b>(NASDAQ: DRIO) (the "Company", "<span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth</span>" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced another Fortune 50 employer has selected Dario to provide its integrated digital cardiometabolic care platform for employees http://www.streetinsider.com/Press+Releases/Fortune+50+Employer+Awards+Dario+Contract+to+Deliver+AI-Powered+Cardiometabolic+Care+Platform/26776700.html Thu, 16 Jul 2026 07:30:00 -0400 DRIO LS1P O.15219032 http://www.streetinsider.com/Press+Releases/Fortune+50+Employer+Awards+Dario+Contract+to+Deliver+AI-Powered+Cardiometabolic+Care+Platform/26776700.html <div class="xn-content"> <p class="prntac"><i>Contract award for over 100,000 eligible employees marks Dario's fifth Fortune 50 client, further reflecting growing demand among large employers for integrated, outcomes-driven chronic condition management</i></p><p class="prntac"><i>Program expected to launch Fall 2026, with revenue contribution beginning by year-end and ramping through 2027</i></p><p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 16, 2026</chron></span> /PRNewswire/ -- <b><span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth Corp.</span> </b>(NASDAQ: DRIO) (the "Company", "<span value="NASDAQ-SMALL:DRIO" idsrc="xmltag.org" >DarioHealth</span>" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced another Fortune 50 employer has selected Dario to provide its integrated digital cardiometabolic care platform for employees http://www.streetinsider.com/Press+Releases/Fortune+50+Employer+Awards+Dario+Contract+to+Deliver+AI-Powered+Cardiometabolic+Care+Platform/26776700.html Thu, 16 Jul 2026 07:30:00 -0400 DRIO LS1P O.15219032